OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production within Chinese hamster ovary (CHO) cells presents a paramount challenge with the biopharmaceutical industry. Various strategies are employed enhance antibody titer, such as process parameter optimization, genetic engineering, and implementation of perfusion processes. Fine-tuning media compositi